Source document
Glaxo whistleblowers to pocket $250m for coming forward
News and industry documents belong to their publishers: we link to them and quote briefly, but don’t share copies.
Has everything in it been taken?
Not reviewed
Nobody has yet checked the whole document against what was taken from it. There may be more in it.
What it supports
1 row on this site come from this document. Each one opens with the page and the exact words.
About the document
What it covers Reported relator share in the GSK 2012 settlement and the relators' names
Notes Secondary; DOJ's release does not give the relators' share.
Source id gbr-managementtoday-gsk-relators-2012 · accessed 3 Oct 2026